Stock 300558 BETTA PHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Betta Pharmaceuticals Co., Ltd.

Equities

300558

CNE100002DD9

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 29/04/2024 BST 		5-day change 1st Jan Change
41.73 CNY +0.34% Intraday chart for Betta Pharmaceuticals Co., Ltd. +8.96% -19.05%
04-19 Betta Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
01-04 C4 Therapeutics, Inc. announced that it has received $24.999997 million in funding from Betta Pharmaceuticals Co., Ltd. CI

Evolution of the average Target Price on Betta Pharmaceuticals Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

5a5ab86ef31d6f009.ELlLjpaVqOHcqUOVchSid0ytyOqTIdjdUdeBLcBdv7M.Q_sG6uDRwbW3ywXyI3jBIgLqgd3JR4q-FO_RR6k50MIg1DPn5OXnoJf5NA~70c2f264eff67f67bc2fe79eaf9525fa

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
41.73 CNY
Average target price
50.98 CNY
Spread / Average Target
+22.15%
High Price Target
60 CNY
Spread / Highest target
+43.78%
Low Price Target
41.95 CNY
Spread / Lowest Target
+0.53%

Consensus detail

Consensus revision (last 18 months)

Ratings for Betta Pharmaceuticals Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 300558 Stock
  4. Consensus Betta Pharmaceuticals Co., Ltd.